Track the NeuPath Health Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €31.3m. The latest transaction was reported on 28 August 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: NeuPath Health Inc.. The full history is free.
47
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NeuPath Health Inc. Strong Buy (bullish), based on 2 analysts. Average price target: CA$0.77.
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,919 of 29,064 companies
39.5
score / 100
Value
48
Quality
31
FCF yld9.8%
Earn yld-2.2%
EV/EBITDA14.4x
ROE7.2%
Gross mgn19%
Net mgn-0.8%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.